4 results match your criteria: "Jagiellonian University Children's Hospital[Affiliation]"
Indian J Thorac Cardiovasc Surg
April 2019
Department of Pediatric Cardiac Surgery, Jagiellonian University Children's Hospital, Ul. Wielicka 265, 30-663 Krakow, Poland.
Hypoplastic left heart syndrome (HLHS) is the most severe form of congenital heart defect (CHD). The first successful intervention for it was undertaken by Norwood in 1983. Since then, there have been much development in the pre, intra, and postoperative treatment option in staged palliative surgical procedures.
View Article and Find Full Text PDFFolia Med Cracov
September 2019
Department of Pediatric Cardiac Surgery, Jagiellonian University Children's Hospital, Wielicka 265, Kraków,
The Aim: The aim of the study is to present the initial experience with continuous flow left ventricle assist device (CF-LVAD) in pediatric patients with BSA below 1.5 m2.
Material And Methods: Between 2016 and 2017, CF-LVAD (the Heartware System) have been implanted in three pediatric patients in the Department of Pediatric Cardiac Surgery, Jagiellonian University, Krakow, Poland.
Indian J Thorac Cardiovasc Surg
July 2018
Department of Pediatric Cardiac Surgery, Jagiellonian University Children's Hospital, Krakow, Poland.
Purpose: The Norwood procedure, the first surgical step of staged palliation for hypoplastic left heart syndrome (HLHS), is also applied for other complex single ventricle lesions. This study aimed to evaluate the outcome of the Norwood operation in a single center over 4 years and to identify clinical and anatomic risk factors for overall mortality.
Methods: A retrospective review of the pediatric cardiovascular surgery database was performed to identify infants with HLHS who underwent NP (Norwood procedure) at our institution between January 2007 and December 2011.
Contemp Oncol (Pozn)
May 2014
Department of Pediatric Hematology and Oncology, Pediatric Center Chorzow, Poland.
Aim Of The Study: Recent studies showed relatively better outcome for children with refractory (refAML) and relapsed acute myeloid leukemia (relAML). Treatment of these patients has not been unified within Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG) so far. The goal of this study is to analyze the results of this therapy performed between 2005-2011.
View Article and Find Full Text PDF